Raksha Bhat

Raksha Bhat

University of Houston

H-index: 10

North America-United States

About Raksha Bhat

Raksha Bhat, With an exceptional h-index of 10 and a recent h-index of 10 (since 2020), a distinguished researcher at University of Houston, specializes in the field of Cancer, Circulating tumor cells (CTCs), adhesion GPCRs, Cancer immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer

Screening of GPCR drugs for repurposing in breast cancer

ADGRF1 promotes tumorigenesis via the activation of STAT3 pathway in HER2+ and triple‐negative breast cancers

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

The IRE1/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism

MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms

Developing an immunofluorescence assay for detecting Rb and phospho-Rb on circulating tumor cells in breast cancer

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

Raksha Bhat Information

University

Position

___

Citations(all)

367

Citations(since 2020)

289

Cited By

180

hIndex(all)

10

hIndex(since 2020)

10

i10Index(all)

12

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Raksha Bhat Skills & Research Interests

Cancer

Circulating tumor cells (CTCs)

adhesion GPCRs

Cancer immunotherapy

Top articles of Raksha Bhat

Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer

Cancer Research

2023/3/1

Screening of GPCR drugs for repurposing in breast cancer

Frontiers in Pharmacology

2022/12/6

ADGRF1 promotes tumorigenesis via the activation of STAT3 pathway in HER2+ and triple‐negative breast cancers

The FASEB Journal

2022/5

Raksha Bhat
Raksha Bhat

H-Index: 8

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

Scientific Reports

2022/2/4

The IRE1/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism

Elife

2021/11/23

MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms

FASEB journal: official publication of the Federation of American Societies for Experimental Biology

2021/8

Developing an immunofluorescence assay for detecting Rb and phospho-Rb on circulating tumor cells in breast cancer

Cancer Research

2021/7/1

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

The FASEB Journal

2021/7

ADGRF1 signaling pathways in Breast Cancer

The FASEB Journal

2020/4

Abstract P3-06-07: ADGRF1 overexpression inhibits tumor growth in vivo by inducing cell cycle arrest in HER2+ breast cancer

Cancer Research

2020/2/15

ADGRG1 promotes tumorigenesis, invasion/migration, and cell-cell adhesion in triple-negative breast cancer cells

Cancer Research

2020/8/15

Raksha Bhat
Raksha Bhat

H-Index: 8

Hariprasad Thangavel
Hariprasad Thangavel

H-Index: 6

Design, optimization, and validation of multiplex immunofluorescence assay for detecting biomarker expression on circulating tumor cells in breast cancer

Cancer Research

2020/8/15

See List of Professors in Raksha Bhat University(University of Houston)